Allergan to spend $2.48 billion to buy CoolSculpting provider Zeltiq

Standard

Botox maker Allergan is spending about $2.48 billion to buy Zeltiq Aesthetics Inc. and its CoolSculpting system for reducing fat.

Allergan said it will pay $56.50 for each share of Zeltiq in a deal it expects to close in the second half of this year. That represents a 14% premium to Zeltiq’s $49.40…

fromhttp://www.baltimoresun.com/business/la-fi-allergan-zeltiq-coolsculpting-20170213-story.html

Advertisements